A critical feature of CLSI M22-A3 is the classification of culture media into two categories, allowing laboratories to save time and resources. 1. Exempt Media
Conclusion CLSI M22-A3 is an essential, authoritative resource for performing and interpreting antimicrobial disk diffusion testing. Its detailed methodological instructions, QC criteria, and interpretive breakpoints promote reliable laboratory results, safer clinical decision-making, and robust surveillance of antimicrobial resistance. Accessing the official PDF through CLSI or authorized institutional channels ensures laboratories use the correct, current standards and maintain legal and professional compliance.
The document, fully titled is a guideline published by the Clinical and Laboratory Standards Institute (CLSI). The "A3" designates this as the third edition of the approved guideline.
Ensure that the manufacturer's quality control certificate referencing compliance with CLSI M22-A3 is on file.
CLSI M22-A3 PDF Link: Guide to Quality Control for Commercially Prepared Culture Media clsi m22a3 pdf link
This article provides an in-depth look at the , why it is critical, how it helps laboratories save resources, and where to find the document. What is CLSI M22-A3?
CLSI M22-A3 PDF Link: A Guide to Commercially Prepared Microbiological Culture Media Standards
Some public libraries and online databases offer access to technical documents, sometimes for a fee. However, be cautious when using third-party sites to ensure you're accessing the most current and legitimate version of the document.
Microbiology laboratories historically performed full, rigorous QC testing on every single batch of media received, regardless of the manufacturer's internal testing. Recognizing that modern commercial manufacturing processes are highly controlled and reliable, CLSI introduced the M22 standard to reduce unnecessary, redundant testing while maintaining strict patient safety standards. The Core Philosophy: Exempt vs. Non-Exempt Media A critical feature of CLSI M22-A3 is the
: Procedures for when a medium fails to perform as expected, regardless of its exempt status. Conclusion
The CLSI M22-A3 standard is a critical resource for laboratories, providing guidelines for the collection, transport, and processing of clinical specimens. By following these guidelines, laboratories can ensure the accuracy and reliability of test results, prioritize patient safety, and maintain regulatory compliance. You can access the CLSI M22-A3 PDF version using the link provided above.
It is crucial to understand that . While the quality of AST media is paramount, the specific quality control recommendations for media used in AST (e.g., Mueller-Hinton agar) are detailed in separate, dedicated CLSI documents, such as M02 and M07.
The CLSI M22-A3 standard is essential for ensuring the accuracy and reliability of laboratory test results. Proper handling and processing of clinical specimens are critical for: The "A3" designates this as the third edition
Since January 2016, US labs subject to CLIA regulations often move toward Individualized Quality Control Plans (IQCP), but M22-A3 remains a technically valid and valuable resource in the CLSI library. Why Standards Matter in 2026 Even as we look toward 2026 CLSI guidelines
Design robust, compliant inspection checklists for incoming inventory. How to Access the Legitimate CLSI M22-A3 PDF Link
: Maintaining strains in a way that prevents genetic drift or loss of viability.
CLSI M22-A3 is an approved standard that provides quality assurance procedures for both manufacturers and of prepared, ready-to-use microbiological culture media. Published in June 2004 , it represents the third edition of the M22 standard, replacing the previous version, M22-A2, which was published in December 1996.
CLSI M22-A3, titled "Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard—Third Edition," outlines the responsibilities of both manufacturers and clinical laboratories regarding the quality assurance of growth media.